PFIZER share price jumps after compromise with Mylan Pharmaceuticals

PFIZER share price jumps after compromise with Mylan Pharmaceuticals


The scrip rose by 8.52% to Rs 4,444, the highest level since 7 February. It trade 6% more trading at Rs 4,340.95 to 6% more trading, compared to the decline of 0.88% in NSE by 11:59 pm. Nifty 50.

It has increased by 1.16% in the last 12 months. Till now the total amount of business in the day was 46 times its 30-day average. The relative power index was at 46.

According to Bloomberg data, two of the three analysts monitoring the company maintains ‘buy’ ratings and one recommends ‘hold’. The average 12 -month analysts have a consensus value target 37.6%.

(Tagstotransite) Fizer Limited